Head to Head Review: NeurAxis (NASDAQ:NRXS) vs. Viveve Medical (NASDAQ:VIVE)

NeurAxis (NASDAQ:NRXS) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations.

Risk & Volatility

NeurAxis has a beta of 4.3, indicating that its stock price is 330% more volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.54, indicating that its stock price is 46% less volatile than the S&P 500.

Valuation and Earnings

This table compares NeurAxis and Viveve Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeurAxis	$2.27 million	8.00	-$14.63 million	($2.94)	-0.90
Viveve Medical	$6.83 million	0.00	-$22.03 million	N/A	N/A

NeurAxis has higher earnings, but lower revenue than Viveve Medical.

Analyst Recommendations

This is a breakdown of current ratings and target prices for NeurAxis and Viveve Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeurAxis	0	0	0	0	N/A
Viveve Medical	0	0	0	0	N/A

Institutional & Insider Ownership

11.8% of NeurAxis shares are owned by institutional investors. 15.2% of NeurAxis shares are owned by company insiders. Comparatively, 5.7% of Viveve Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares NeurAxis and Viveve Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeurAxis	-672.66%	N/A	-787.15%
Viveve Medical	N/A	N/A	N/A

Summary

NeurAxis beats Viveve Medical on 5 of the 8 factors compared between the two stocks.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

About Viveve Medical

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.